Fresca Medical, Inc. Completes Initial Close of Series C Preferred Stock Financing

Represented Fresca Medical, Inc. with the initial close of its Series C Preferred Stock financing, raising $3.6 million of an anticipated total financing of $6 million. Vincent Medical, Inc. acted as lead investor. Fresca Medical Inc, a Delaware corporation, specializes in developing medical devices for the treatment of sleep apnea.